Gilead Sciences, Inc. (NASDAQ:GILD) plans to present over 20 research abstracts—spanning both Gilead and its cell therapy unit Kite—at two major medical conferences: the 2025 ASCO Annual Meeting (May ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, ...

The presentation will be available at Poster Board #271. The ASCO Annual Meeting is the premier event for advancing clinical oncology, where professionals connect and collaborate. It also offers ...

Heather McArthur, MD, looks forward to ASCO 2025, where several pivotal studies in breast cancer will be presented. Key highlights include the DESTINY-Breast09 trial, which showed a significant ...

After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, AbbVie is advancing its solid tumor ambitions with a new FDA green light.

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at ...

The 2025 ASCO Annual Meeting will feature over 200 sessions and more than 5,000 posters complementing the theme, "Driving Knowledge to Action: Building a Better Future," reflecting the meeting’s ...